NCT01667900View on ClinicalTrials.gov

A Study of Dulaglutide in Chinese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Diabetes Mellitus, Type 2Healthy Volunteers
Interventions
DRUG

Dulaglutide

DRUG

Placebo

Administered SQ in the placebo arms and to maintain the blind in the dulaglutide arms.

Trial Locations (1)

100034

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Beijing

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01667900 - A Study of Dulaglutide in Chinese Participants | Biotech Hunter | Biotech Hunter